Strongbridge Biopharma plc
SBBP
Get informed when a big investor buys or sells
+ FollowMarket Cap$0
Close$
$3.54
77% upside
Current Fair Value
77% upsideUndervalued by 77% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $0.00 |
|---|---|
| Enterprise Value | $-45,619,000.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.8 |
| Beta | 1.6 |
| Outstanding Shares | 67,653,659 |
Return
| Return on Equity | -90.47% |
|---|---|
| Return on Assets | -41.48% |
| Return on Invested Capital | -51.06% |
Valuation & Multiples
| P/E Ratio | -2.49 |
|---|---|
| PEG | 10.67 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | -1.31 |
| Enterprise Value to EBIT | 1.22 |
| Enterprise Value to Net Income | 1 |
| Total Debt to Enterprise | -0.4 |
| Debt to Equity | 0.41 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Strongbridge Biopharma plc
CEO: Matthew Pauls